Dr. Brown on Genetic Counseling for Breast and Ovarian Cancer

Jubilee Brown, MD
Published: Monday, Mar 13, 2017



Jubilee Brown, MD, obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

With a multi-pronged approach that included physician and provider engagement and education, patient navigation, genetic counseling services, and telegenetics, there was an increase in the number of patients who were referred with ovarian cancer from 37% to 96% within a 2-year period.

This was then able to be reproduced for patients with breast cancer. Additionally, there was an increase in patients who were tested from 24% to over 50% in the same 2-year period, explains Brown.



Jubilee Brown, MD, obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

With a multi-pronged approach that included physician and provider engagement and education, patient navigation, genetic counseling services, and telegenetics, there was an increase in the number of patients who were referred with ovarian cancer from 37% to 96% within a 2-year period.

This was then able to be reproduced for patients with breast cancer. Additionally, there was an increase in patients who were tested from 24% to over 50% in the same 2-year period, explains Brown.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x